Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance
- PMID: 27197162
- DOI: 10.1158/0008-5472.CAN-15-2998
Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance
Abstract
Angiogenesis plays a crucial role in tumor growth, with an undisputed contribution of resident endothelial cells (EC) to new blood vessels in the tumor. Here, we report the definition of a small population of vascular-resident stem/progenitor-like EC that contributes predominantly to new blood vessel formation in the tumor. Although the surface markers of this population are similar to other ECs, those from the lung vasculature possess colony-forming ability in vitro and contribute to angiogenesis in vivo These specific ECs actively proliferate in lung tumors, and the percentage of this population significantly increases in the tumor vasculature relative to normal lung tissue. Using genetic recombination and bone marrow transplant models, we show that these cells are phenotypically true ECs and do not originate from hematopoietic cells. After treatment of tumors with antiangiogenic drugs, these specific ECs selectively survived and remained in the tumor. Together, our results established that ECs in the peripheral vasculature are heterogeneous and that stem/progenitor-like ECs play an indispensable role in tumor angiogenesis as EC-supplying cells. The lack of susceptibility of these ECs to antiangiogenic drugs may account for resistance of the tumor to this drug type. Thus, inhibiting these ECs might provide a promising strategy to overcome antiangiogenic drug resistance. Cancer Res; 76(11); 3200-10. ©2016 AACR.
©2016 American Association for Cancer Research.
Similar articles
-
Rapid vascular regrowth in tumors after reversal of VEGF inhibition.J Clin Invest. 2006 Oct;116(10):2610-21. doi: 10.1172/JCI24612. J Clin Invest. 2006. PMID: 17016557 Free PMC article.
-
The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels.Angiogenesis. 2004;7(3):225-33. doi: 10.1007/s10456-004-3149-y. Angiogenesis. 2004. PMID: 15609077
-
Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.J Cell Biochem. 2012 May;113(5):1478-87. doi: 10.1002/jcb.24085. J Cell Biochem. 2012. PMID: 22298358
-
Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme.Neurosurg Focus. 2006 Apr 15;20(4):E22. doi: 10.3171/foc.2006.20.4.e22. Neurosurg Focus. 2006. PMID: 16709028 Review.
-
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.Eur Cytokine Netw. 2009 Dec;20(4):225-34. doi: 10.1684/ecn.2009.0175. Eur Cytokine Netw. 2009. PMID: 20167562 Review.
Cited by
-
Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23.Sci Rep. 2020 Oct 14;10(1):17319. doi: 10.1038/s41598-020-74352-x. Sci Rep. 2020. PMID: 33057033 Free PMC article.
-
Identification of CD157-Positive Vascular Endothelial Stem Cells in Mouse Retinal and Choroidal Vessels: Fluorescence-Activated Cell Sorting Analysis.Invest Ophthalmol Vis Sci. 2022 Apr 1;63(4):5. doi: 10.1167/iovs.63.4.5. Invest Ophthalmol Vis Sci. 2022. PMID: 35394492 Free PMC article.
-
The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.Front Cell Dev Biol. 2021 May 20;9:637675. doi: 10.3389/fcell.2021.637675. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34095111 Free PMC article. Review.
-
The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential.Cancer Commun (Lond). 2021 Oct;41(10):981-1006. doi: 10.1002/cac2.12194. Epub 2021 Jul 20. Cancer Commun (Lond). 2021. PMID: 34289530 Free PMC article. Review.
-
Bioresponsive cancer-_targeted polysaccharide nanosystem to inhibit angiogenesis.Int J Nanomedicine. 2017 Oct 10;12:7419-7431. doi: 10.2147/IJN.S139405. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29066892 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials